This account is dormant. Find me on other platforms.

Joined December 2011
97 Photos and videos
Pinned Tweet
Should we still do #DOT for #TB? My article is now out in Human Organization. Here is the open access link: tandfonline.com/doi/full/10.… (thanks to @WayneStateCLAS @AnthroAtWayne & @waynestate OVPR for support) @SfAAnthro @sshiftb @TBECoalition @StopTBUSA @TAGTeam_Tweets @StopTB
2
12
18
1,199
Happening right now: Highlights from NAR – Reframing Directly Observed Treatment Wednesday, May 7th, 2025 10:30 am - 1:00 pm (Pacific Time) (1:30-4:00pm Eastern Time) ucsf.zoom.us/j/94018665760?p… #tb @StopTBUSA @TBFighters @realTBpeople @TBECoalition
1
2
93
Highlights from NAR – Reframing Directly Observed Treatment Wednesday, May 7th, 2025 10:30 am - 1:00 pm (Pacific Time) (1:30-4:00pm Eastern Time) Registration Deadline: Tuesday, May 6th, 2025 Register here: currytbcenter.ucsf.edu/train… @StopTB #tb @TheUnion_TBLH @realTBpeople

62
Jonathan J Stillo retweeted
20 Feb 2025
Note our TIME CHANGE! Our Annual Membership Meeting will happen on Friday, February 28th at 5:00pm Pacific and 8:00pm Eastern Time. We can't wait to see you there!! #endtb #stoptb #stoptbnow
1
1
97
Jonathan J Stillo retweeted
The deadline for collection of candidate's applications for joining the TBEC Board is extended till 26th December 2024! More information ➡️ tbcoalition.eu/news/nominati…
4
5
221
XDR #TB is a #GlobalHealth emergency. Clinicians, affected community, and other experts have come together to create a field guide for managing TB with expanded resistance. Please share widely. @TAGTeam_Tweets @TBECoalition @StopTBUSA tbcenter.jhu.edu/wp-content/…

3
5
242
Jonathan J Stillo retweeted
Delamanid is now part of WHO-recommended short-course DR-TB regimens, so access is more urgent than ever. Recent price ⬇️ is good step, but doesn't go far enough! We've fought for delamanid access for years (see pics!) will continue. 1/4/6x24 statement: treatmentactiongroup.org/sta…
4
9
360
Jonathan J Stillo retweeted
People w/ extensively drug-resistant TB have the fewest treatment options. Addressing their needs reimagining pre-approval access mechanisms, urges a growing consensus of researchers TB survivors. New statement from the TB CAB: globaltbcab.org/statement/pr…
7
12
458
Jonathan J Stillo retweeted
15 Nov 2024
Amazing findings! Debrah Vambe sharing findings @UnionConference from Eswatini highlights profound gaps in existing diagnostic algorithms that potentially miss Bdq resistance (and clofazimine) among diagnosed INH-or MDRTB-resistant! This data is from 2021-2022!!
1
2
6
645
Jonathan J Stillo retweeted
15 Nov 2024
Critical insights being shared right now by Paran - a TB survivor and brilliant speaker @UnionConference! She asks us all: We don’t have longer regimens, and no injectables for a majority of #MDRTB patients … but what is our plan B if the shorter regimens fail?
2
6
394
Jonathan J Stillo retweeted
A message for Pharmaceutical Corporations Otsuka and Viatris- Make Delamanid Affordable Now! Price of this drug still remains high at $1100 by Otsuka and $800 by Viatris. If we really want to see wider scale up and save lives of people, price need to go down.
1
15
20
1,937
Jonathan J Stillo retweeted
Let us share with you a publication "Building social equity and person-centred innovation into the end TB response" - ingentaconnect.com/content/i…, which addresses a social science perspective on equity and the TB response.
1
3
80
Jonathan J Stillo retweeted
"60% of LICs and 25% of MICs are in debt stress, 3.3 B people live in countries that spend more on interest payments than on education or health. Urgent #debtrelief and restructuring is needed to free up fiscal space for health." - @doctorsoumya @UnionConference #Unionconf2024
1
9
14
1,081
Jonathan J Stillo retweeted
More than 70 TB activists from around the world called on @DanaherCorp and @CepheidNews at the @UnionConference to make all GeneXpert cartridges affordable for all and also to open their books and share the audit.
3
30
58
2,892